Page last updated: 2024-08-21

alpha-aminopyridine and Epstein-Barr Virus Infections

alpha-aminopyridine has been researched along with Epstein-Barr Virus Infections in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Fu, HR; Gao, QQ; Huang, H; Shi, JM; Tan, YM; Yang, TT; Zhao, YM	1
Esquivel, CO; Hatton, O; Krams, SM; Lambert, SL; Martinez, OM; Natkunam, Y; Phillips, LK; Vaysberg, M	1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Epstein-Barr Virus Infections

Article	Year
Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide. Chinese medical journal, 2021, 04-14, Volume: 134, Issue:22 Topics: Aminopyridines; Benzamides; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Histone Deacetylase Inhibitors; Humans; Lymphoproliferative Disorders; T-Lymphocytes	2021
Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:4 Topics: Aminopyridines; Animals; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred NOD; Mice, SCID; Morpholines; Oxazines; Phosphatidylinositol 3-Kinases; Postoperative Complications; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; Syk Kinase; Transplantation, Heterologous	2013

Article

Year

Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide.

Chinese medical journal, 2021, 04-14, Volume: 134, Issue:22

Topics: Aminopyridines; Benzamides; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Histone Deacetylase Inhibitors; Humans; Lymphoproliferative Disorders; T-Lymphocytes

2021

Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:4

Topics: Aminopyridines; Animals; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred NOD; Mice, SCID; Morpholines; Oxazines; Phosphatidylinositol 3-Kinases; Postoperative Complications; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; Syk Kinase; Transplantation, Heterologous

2013